GlassScriptPhysician profile
Andrew C Thymius
NPI 1083707855
$9,304.59
in general payments reported to CMS, 2019-2025
14 companies · $1,942 in 2025
The $1,942 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,899 · 2020: $1,099 · 2021: $779 · 2022: $489 · 2023: $1,563 · 2024: $1,535 · 2025: $1,942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,390 · Travel and Lodging: $1,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,390.03 |
| Travel and Lodging | $1,649.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,540.53 | 2019-2025 | Proclaim, Eterna, Nt2000ix |
| Boston Scientific Corporation | $1,945.11 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Si-Bone, INC. | $980.71 | 2019-2024 | |
| Curonix LLC | $406.50 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $114.54 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $113.74 | 2024 | Evoke |
| Relievant Medsystems, INC. | $72.77 | 2023 | Intracept |
| Stryker Corporation | $21.01 | 2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $20.50 | 2019 | |
| Medtronic USA, INC. | $20.39 | 2020 | |
| Nevro Corp. | $19.78 | 2023 | Senza |
| Vertiflex, INC. | $18.26 | 2019 | |
| Medtronic, INC. | $16.46 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Thymius listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.